BENJAMIN R YERXA
CIK 1145910 · President · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
39
Lifetime Open-Market Net
-$173.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. (OCUP) Delisted | President | 711,535 | $1.17 | $832.5K | -$29.3K | 5 | 2026-04-27 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 1,197 | $0.35 | $421 | $10.2K | 5 | 2024-06-21 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | EVP & Chf, Research & Develop | 53,857 | — | — | -$154.1K | 27 | 2010-05-13 |
Recent Filings · Page 2 of 4
39 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-04 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-13 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-05 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Sell (S) | −2,000 | -$13.5K | EDGAR |
| 2010-04-05 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Sell (S) | −2,000 | -$12.6K | EDGAR |
| 2010-03-22 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-03-03 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Sell (S) | −2,000 | -$12.3K | EDGAR |
| 2010-02-02 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Sell (S) | −2,000 | -$10.8K | EDGAR |
| 2010-01-05 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Sell (S) | −2,000 | -$11.2K | EDGAR |
| 2009-12-02 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Sell (S) | −2,000 | -$11.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.